Finally, we were interested in whether the added specificity of our cellular composition estimates could enhance our understanding of the neuropathology of Alzheimer’s disease using data from recent analyses of DNAm differences associated with tau and amyloid pathology using bulk cortex [31]. The gene discussed is MAPT; the disease is Alzheimer disease.